Little Green Pharma (ASX:LGP) Acquires Health House Distribution Business
Little Green Pharma (ASX:LGP) acquires Health House distribution business for $375,000, enhancing its vertical integration and strategic growth.
Little Green Pharma (ASX:LGP) acquires Health House distribution business for $375,000, enhancing its vertical integration and strategic growth.
Audeara Limited (ASX:AUA) secures a US$917,000 purchase order, validating its AUA Technology’s commercial potential in global markets.
Biome Australia Limited (ASX:BIO) secures a co-investment with FaBA to develop its BMB18 probiotic strain, supported by government funding.
Pro Medicus Limited (ASX:PME) secures a A$53M, 7-year contract with BayCare to implement its Visage 7 Enterprise Imaging Platform.
Rhythm Biosciences (ASX:RHY) completes Genetype integration, enhancing commercial operations for geneType™ and ColoSTAT® products.
Beamtree Holdings Limited (ASX:BMT) appoints Marek Stepniak as new CEO to drive global growth and innovation in the healthcare sector.
OncoSil Medical (ASX:OSL) expands its presence in Germany with a 43% increase in hospitals authorized to negotiate funding for its innovative OncoSil™ device.
Wellnex Life (ASX:WNX) secures TGA approval for its Liquid Paracetamol plus Caffeine Soft Gel, expanding its healthcare portfolio and revenue opportunities.
BIOTRON LIMITED (ASX:BIT) announces a net operating cash inflow of $1.095M for Q4, maintaining a strong cash position.
Medlab Clinical Limited (ASX:MDC) announces Q2 2025 business update, including AGM plans and ASX removal, with a closing cash balance of $5K.